Antigen News and Research

RSS

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Alternative forms of two genes are associated with a boost in immunity to hepatitis C after childbirth, a study led by a Nationwide Children's Hospital physician-researcher shows.

31 Oct 2016

Researchers develop new way to test strength of immune response

The immune system orchestrates large and small scale attacks on innumerous targets: viruses, bacteria, cancer, but it also misfires causing allergy or autoimmune reactions.

27 Oct 2016

Scientists identify commonly affected genes sets among people with three mental disorders

Studying brain tissue from deceased donors, Johns Hopkins scientists have found common groups of genes disrupted among people with schizophrenia, bipolar disorder and major depression.

26 Oct 2016

New approach could overcome large immunosuppressive tumors

Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.

24 Oct 2016

TSRI scientists discover reason for lack of successful HCV vaccine design

Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute have discovered one reason why success has so far been elusive.

24 Oct 2016

Novel approach could help counter Influenza A virus in immune-compromised patients

To infect its victims, influenza A heads for the lungs, where it latches onto sialic acid on the surface of cells.

24 Oct 2016

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.

24 Oct 2016

Scientists discover new receptors for stomach bacterium Helicobacter pylori

A research group led by Prof. Markus Gerhard of the Technical University of Munich and Assistant Professor Dr. Bernhard B. Singer of the Institute for Anatomy at the Faculty of Medicine of the University of Duisburg-Essen at Essen University Medical Centre has discovered a completely new approach to preventing or treating infections with this bacterium as well as secondary complications.

19 Oct 2016

Researchers discover new approach to preventing H. pylori linked to stomach infections

Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.

18 Oct 2016

New discovery helps explain why HIV infection increases risk for active tuberculosis

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.

18 Oct 2016

SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

The mouth is widely considered the dirtiest part of the human body, yet babies have surprisingly low infection rates following cleft lip and palate surgery.

18 Oct 2016

Clinical Genomics’ blood test detects twice the number of colorectal cancer recurrence cases than CEA testing

Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its two-gene circulating tumor DNA (ctDNA) blood test for post-surgical monitoring of colorectal cancer (CRC) recurrence have been published online by Cancer Medicine, and will appear in the October issue.

14 Oct 2016

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Staphylococcal and streptococcal infections affect millions of individuals each year. They are a leading cause of sepsis and account for many cases of pneumonia and post-surgical infections.

8 Oct 2016

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first time today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Colostrum is a thick, sticky, yellowish mammary secretion that all mammals provide to their newborns during the first 24-48 hours after delivery.

7 Oct 2016

IDRI awarded two-year NIH grant to develop novel RNA-based Zika virus vaccine

As Zika cases continue to rise around the world -- and in the United States -- with associated increases in Guillain-Barre syndrome and congenital birth defects, the need for a safe and effective vaccine to protect against Zika virus is greater than ever.

6 Oct 2016

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.

6 Oct 2016

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of patients whose prostate cancer returns after surgery.

6 Oct 2016

Scientists aim to explore parasite's genomic architecture for varying expression of antigens

Many serious diseases such as malaria or AIDS present a major challenge for medicine because the causative pathogens use the same strategy although they are completely different: By camouflaging themselves they evade the immune system.

6 Oct 2016

Biofortuna achieves key milestones in development of new blood group genotyping product family

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has successfully achieved key milestones in the development of its new blood group genotyping product family – ReadyPlex™.

5 Oct 2016

Antigen News and Research

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Researchers develop new way to test strength of immune response

Scientists identify commonly affected genes sets among people with three mental disorders

New approach could overcome large immunosuppressive tumors

TSRI scientists discover reason for lack of successful HCV vaccine design

Novel approach could help counter Influenza A virus in immune-compromised patients

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

Scientists discover new receptors for stomach bacterium Helicobacter pylori

Researchers discover new approach to preventing H. pylori linked to stomach infections

New discovery helps explain why HIV infection increases risk for active tuberculosis

SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

Clinical Genomics’ blood test detects twice the number of colorectal cancer recurrence cases than CEA testing

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

IDRI awarded two-year NIH grant to develop novel RNA-based Zika virus vaccine

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

Scientists aim to explore parasite's genomic architecture for varying expression of antigens

Biofortuna achieves key milestones in development of new blood group genotyping product family

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News